Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04442152Not ApplicableCompleted

Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants

Role: lead

NCT04861870Not ApplicableCompleted

Bandebereho 6 Year Follow up RCT in Rwanda

Role: lead

NCT04962802Not ApplicableCompleted

Evaluation of Manhood 2.0: A Community-Based Teen Pregnancy Prevention Program for Young Men

Role: collaborator

NCT02694627Not ApplicableCompleted

Bandebereho Father Groups Randomized Control Trial in Rwanda

Role: lead

All 4 trials loaded